magnolol has been researched along with Urinary Bladder Neoplasms in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, JH; Hsu, FT; Jeng, LB; Lee, SR; Liu, WL | 1 |
| Chen, MC; Chou, TC; Huang, WH; Lee, CF | 1 |
| Chen, MC; Chen, YL; Chou, TC; Hung, CH; Lee, CF | 1 |
| Kim, WJ; Lee, SJ; Lee, US; Moon, SK; Park, SS | 1 |
| Cho, YH; Jung, KH; Kim, EJ; Kim, WJ; Lee, SJ; Moon, SK; Park, K; Park, SS | 1 |
5 other study(ies) available for magnolol and Urinary Bladder Neoplasms
| Article | Year |
|---|---|
Unveiling nature's potential weapon: Magnolol's role in combating bladder cancer by upregulating the miR-124 and inactivating PKC-δ/ERK axis.
Topics: Animals; Apoptosis; Biphenyl Compounds; Cell Line, Tumor; Cell Proliferation; Lignans; MicroRNAs; NF-kappa B; Urinary Bladder Neoplasms | 2023 |
Magnolol suppresses hypoxia-induced angiogenesis via inhibition of HIF-1α/VEGF signaling pathway in human bladder cancer cells.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents, Phytogenic; Biphenyl Compounds; Cell Hypoxia; Cell Line, Tumor; Chickens; Chorioallantoic Membrane; Female; Human Umbilical Vein Endothelial Cells; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Lignans; Mice; Mice, Nude; Neoplasm Transplantation; Neovascularization, Pathologic; Neovascularization, Physiologic; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Signal Transduction; TOR Serine-Threonine Kinases; Transcription, Genetic; Urinary Bladder Neoplasms; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2 | 2013 |
Supplementation of Magnolol Attenuates Skeletal Muscle Atrophy in Bladder Cancer-Bearing Mice Undergoing Chemotherapy via Suppression of FoxO3 Activation and Induction of IGF-1.
Topics: Animals; Biphenyl Compounds; Body Weight; Forkhead Box Protein O3; Forkhead Transcription Factors; Insulin-Like Growth Factor I; Interleukin-6; Lignans; Male; Mice; Mice, Nude; Muscular Atrophy; NF-kappa B; Proteasome Endopeptidase Complex; Tumor Necrosis Factor-alpha; Urinary Bladder Neoplasms | 2015 |
Signaling pathway for TNF-alpha-induced MMP-9 expression: mediation through p38 MAP kinase, and inhibition by anti-cancer molecule magnolol in human urinary bladder cancer 5637 cells.
Topics: Antineoplastic Agents; Biphenyl Compounds; Cell Line, Tumor; Cell Movement; Enzyme Inhibitors; Humans; Imidazoles; Lignans; Matrix Metalloproteinase Inhibitors; NF-kappaB-Inducing Kinase; p38 Mitogen-Activated Protein Kinases; Protein Serine-Threonine Kinases; Pyridines; Signal Transduction; Tumor Necrosis Factor-alpha; Urinary Bladder Neoplasms | 2008 |
Magnolol elicits activation of the extracellular signal-regulated kinase pathway by inducing p27KIP1-mediated G2/M-phase cell cycle arrest in human urinary bladder cancer 5637 cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Biphenyl Compounds; Cell Cycle; Cell Division; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cyclin-Dependent Kinase Inhibitor p27; Dose-Response Relationship, Drug; Enzyme Inhibitors; Extracellular Signal-Regulated MAP Kinases; G2 Phase; Humans; Lignans; Phosphorylation; Signal Transduction; Urinary Bladder Neoplasms | 2008 |